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The ability of the opportunistic pathogen, Staphylococcus aureus, to form biofilms is
increasingly being viewed as an important contributor to chronic infections. In vitro
methods for analyzing S. aureus biofilm formation have focused on bacterial attachment
and accumulation on abiotic surfaces, such as in microtiter plate and flow cell assays.
Microtiter plates provide a rapid measure of relative biomass levels, while flow cells
have limited experimental throughput but are superior for confocal microscopy biofilm
visualization. Although these assays have proven effective at identifying mechanisms
involved in cell attachment and biofilm accumulation, the significance of these assays
in vivo remains unclear. Studies have shown that when medical devices are implanted
they are coated with host factors, such as matrix proteins, that facilitate S. aureus
attachment and biofilm formation. To address the challenge of integrating existing biofilm
assay features with a biotic surface, we have established an in vitro biofilm technique
utilizing UV-sterilized coverslips coated with human plasma. The substratum more closely
resembles the in vivo state and provides a platform for S. aureus to establish a robust
biofilm. Importantly, these coverslips are amenable to confocal microscopy imaging to
provide a visual reference of the biofilm growth stage, effectively merging the benefits of
the microtiter and flow cell assays. We confirmed the approach using clinical S. aureus
isolates and mutants with known biofilm phenotypes. Altogether, this new biofilm assay
can be used to assess the function of S. aureus virulence factors associated with biofilm
formation and for monitoring the efficacy of biofilm treatment modalities.
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INTRODUCTION
Staphylococcus aureus is a Gram-positive bacterial pathogen and
a major public health problem in the United States and other
countries. S. aureus causes a wide range of infections that includes
acute, chronic, and toxinmediated disease (Chambers andDeLeo,
2009; DeLeo and Chambers, 2009). The ability of this pathogen
to cause such a diverse array of problems is due to its arsenal of
virulence factors that include pore-forming toxins, superantigens,
matrix-binding surface adhesins, and tissue-degrading enzymes
(Lowy, 1998). Like many bacterial pathogens, S. aureus can attach
to a surface, accumulate biomass, and form a community of cells
encased in an extracellular matrix called a biofilm (Gotz, 2002;
Kiedrowski and Horswill, 2011). Many chronic infections, such
as endocarditis, osteomyelitis, and growth on medical implants
have biofilm-like features (Parsek and Singh, 2003; Zimmerli
et al., 2004; Costerton, 2005). The formation of biofilms has been
shown to protect the bacteria from host immune defenses as
well as antibiotic therapy (Zimmerli et al., 2004; Costerton, 2005;
Hall-Stoodley and Stoodley, 2005; del Pozo and Patel, 2007), and
they remain an ongoing challenge for treating chronic infections.
Although numerous factors have been demonstrated to be essen-
tial for S. aureus biofilm development, much remains unknown
about the specific mechanisms employed to form and dissemble
biofilm communities (Boles and Horswill, 2011; Kiedrowski and
Horswill, 2011).
Many in vitro assays have been developed to quantify S. aureus
biofilm formation (Cassat et al., 2007). Perhaps the most com-
monly used assay is the direct attachment of the bacteria to
uncoated, polystyrene microtiter plates. While this assay is con-
venient and low-cost, it is becoming evident that many clinical
S. aureus isolates attach poorly to abiotic surfaces (Lauderdale
et al., 2009; Beenken et al., 2010). Studies examining medical
implants indicate that they are coated with host matrix proteins
upon implantation (Francois et al., 1998, 2000), and these host
matrices can serve as a handle that are bound by the numerous
proteins coating the S. aureus surface (Foster and Hook, 1998),
facilitating cell attachment and biofilm accumulation. Matrix
proteins can be coated on microtiter plates to more accurately
reproduce in vivo—like conditions (Cassat et al., 2007), and
in side-by-side comparisons, this strategy accentuates S. aureus
biofilm formation (Beenken et al., 2010). These matrix-coated
plates are convenient for biofilm assays, but they are not ideal in
the experimental transition to confocal microscopy for obtaining
a visual representation of the biofilm structure. Flow cells con-
tinue to be the method of choice for in situ microscopy, but they
are laborious to perform, amenable to only limited experimen-
tal throughput, and require large quantities of media that can
exhaust valuable reagents.
Although the microtiter and flow cells assays are the most
commonly used methods to assess S. aureus biofilm formation
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(Cassat et al., 2007), other related assays have been developed to
examine pathogens such as Enterococcus faecalis and Pseudomonas
aeruginosa during biofilm formation (Goeres et al., 2009; Guiton
et al., 2009). These assays utilize a variety of surfaces for bacte-
rial attachment to assess biofilm formation through microscopy,
staining of the biomass, or viable plate counts. Our goal in this
work was to develop a hybrid biofilm method that drew upon the
benefits of both microtiter-based assays and flow cells. Based on
success in Enterococcus faecalis biofilm studies with coverslips as a
substratum (Guiton et al., 2009), we developed a coverslip-based
approach amenable to S. aureus biofilm studies. Using clinical iso-
lates and strains with characterized mutations, we demonstrated
that the new method is robust and mirrors results obtained with
other biofilm assays.
MATERIALS ANDMETHODS
STRAINS AND GROWTH CONDITIONS
The bacterial strain used in this study was a community-
associated methicillin-resistant S. aureus (CA-MRSA) isolate of
the USA300 pulse field gel group called LAC, hereafter called
“LACWT.” As a negative control, we used a sigma factor B (SigB)
deficient mutant, hereafter called “LACsigB” (Lauderdale et al.,
2009). Additional control strains used in this study include the
USA400 clinical isolate MW2 (Baba et al., 2002) and a LAC
strain with a complete deletion of the ica locus (Lauderdale et al.,
2009). The biofilm phenotypes of LAC WT, LAC ica, LAC
sigB, and the construction of the sigB and the ica muta-
tions, were reported previously (Lauderdale et al., 2009). S. aureus
strains were maintained in tryptic soy broth (TSB) or brain heart
infusion broth (BHI) throughout this work.
PREPARATION OF BIOFILM MICROTITER PLATES
22mm × 22mm polyvinyl plastic coverslips (Raylabcon, cat #20
40 5300) were placed in each well of a six well cell culture plate
(Corning Costar, cat # 3516). Plates with coverslips were then
UV-sterilized in a tissue culture hood for at least 2 h. Heparin
was added 1:1 to human plasma prepared from donors at the
University of Iowa Inflammation Program to prevent clotting.
The prepared human plasma was then diluted in 50mM sodium
bicarbonate solution to a final concentration of 20%. A 2ml
aliquot of either the sodium bicarbonate buffer or the 20%
human plasma solution was added to each of the sterilized wells
with coverslips and incubated at 4◦C overnight. The human
plasma was aspirated off the next day, and the wells and coverslips
were washed twice with 2ml sterile water.
BIOFILM CONDITIONS
Biofilms were grown by subculturing 18 h cultures to a start-
ing OD600 of 0.2 and immediately diluting them 1:100 in BHI
supplemented with 0.4% glucose. A 5ml aliquot of each strain
was added to each of the 3 wells previously coated with human
plasma. Biofilms were allowed to shake at 100 rpm at 37◦C for
18 h. To harvest the biofilms, the media was aspirated off and the
biomass was washed twice with 5ml of sterile water. The biomass
was allowed to air dry and stained for quantification. To assess
biomass, biofilms were stained with 500µl of 0.1% crystal vio-
let for 10min at room temperature. Excess dye was removed and
biofilms were washed with 5ml of sterile water. Before solubiliza-
tion, coverslips were imaged on a Chemi Gel Doc 2000 imaging
station (Bio-Rad Life Sciences, Hercules, CA). Biofilms were air-
dried and the biomass was dissolved in 500µl 33% acetic acid.
A 100µl aliquot was transferred to a 96 well plate and measured
on an Infinite M200 Tecan plate reader at an optical density (OD)
of 635. Biomass was calculated by averaging three coverslips per
strain, and at least seven separate experiments were performed
with similar results.
CONFOCAL MICROSCOPY
All images were captured on a Nikon ECLIPSE C1 confocal laser
scanning microscope (Nikon Inc., Melville, NY) using a 40× lens.
Images were captured using the laser scanning C1 software from
Nikon Inc. For microscopy, biofilms were harvested as described
above and stained with SYTO9 (Invitrogen) and TO-PRO3
(Invitrogen) for 10min in the dark. To prepare the stain, 1µl of
SYTO9wasmixed with 1µl of TO-PRO3 from themanufacturer’s
stocks in 1ml of water. Excess stain was removed by washing
with 5ml of sterile water. Coverslips were mounted on glass slides
using mounting media made from 2.4 g polyvinyl alcohol, 12ml
0.2M Tris base, 6 g glycerol, and 2.5% DABCO (Sigma-Aldrich,
St. Louis, MO) in 25ml H2O and kept at 4◦C until microscopy
was performed. Microscopy was performed with three coverslips
per strain with at least four separate experiments.
RESULTS AND DISCUSSION
DEVELOPMENT OF THE COVERSLIP BIOFILM ASSAY
Using studies on E. faecalis biofilms as a guide (Guiton et al.,
2009), we developed a coverslip biofilm method for S. aureus.
To facilitate cell adherence and biofilm growth of clinical strains
and to develop an assay that more closely resembles an in vivo
state, the coverslips were coated with human plasma to provide
matrix proteins for S. aureus attachment. As a testing strain, we
used LAC WT, which is known to form biofilms in flow cells
(Lauderdale et al., 2009, 2010), but attaches poorly to uncondi-
tioned microtiter plates. After 18 h of growth, LAC WT formed
thick and confluent biofilm structures on the coverslip coated
with 20% human plasma. The coverslips were stained with 0.1%
crystal violet, and images revealed dark, confluent staining across
the surface indicating robust biofilm formation (Figure 1A). To
determine the ability of these strains to attach specifically to
plastic, LAC WT was grown on coverslips without plasma coat-
ing and the staining was markedly reduced (Figure 1B). Biofilm
formation on these coverslips can be quantified through solubi-
lization of crystal violet and measurement of OD. For the LAC
WT biofilm, quantification with plasma coating revealed a sig-
nificant increase vs. uncoated coverslips (OD635 of 1.3 vs 0.35;
Figure 1C).
As a biofilm negative control, we tested the LACsigBmutant
strain, which is deficient in biofilm formation in microtiter assays
and flow cells (Lauderdale et al., 2009; Boles et al., 2010). The
LAC sigB mutant revealed minimal staining across the cover-
slips coated with 20% human plasma, suggestive of poor biofilm
forming capacity (Figure 1A), and the low OD (0.15 at OD635)
supported this assessment (Figure 1C). In previous studies with
flow cells (Lauderdale et al., 2009), and plasma-coated microtiter
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FIGURE 1 | Visualization and quantitation of coverslip biofilms. Biofilms
were formed on plastic coverslips coated with 20% human plasma (A) or left
untreated (B) for LAC WT and LAC sigB mutant. The coverslips were
post-stained with crystal violet and images were taken. (C) Average
measured biomass for plasma-coated or untreated coverslip biofilms for LAC
WT and sigB (C) or USA400 strain MW2 compared with LAC WT (D). In
both (C) and (D), biomass was measured at OD635 and P values were
determined by students two-tailed T -test.
plates (Mootz and Horswill, 2012), the LAC sigB mutant is
defective in biofilm formation, which is consistent with our cover-
slip assay observations. As anticipated, the LACsigBmutant also
developed a poor biofilm on uncoated plastic (Figure 1B) with a
measured OD635 of 0.18 (Figure 1C). The plasma-only control
wells had no bacterial growth or measurable biomass (data not
shown).
To confirm the generality of the new biofilm method, the
clinical isolate MW2 (USA400 PFGE) was grown on plasma-
coated coverslips alongside LAC WT. Post staining revealed that
the MW2 strain formed thick biofilms with an average biomass
of 2.2 at OD635 (Figure 1D), which was slightly higher than
the LAC WT control. This observation is consistent with previ-
ous experiments where MW2 accumulates more biomass than
USA300 strains (Kiedrowski et al., 2011). As another test of the
new method, an LAC strain derivative with the ica::Tet dele-
tion was examined, and this mutation eliminates the ability of
S. aureus to synthesize the polysaccharide intercellular adhesin
(Cramton et al., 1999). In previous flow cell biofilm experiments,
we observed that introduction of the ica deletion into strain
LAC did not generate an in vitro biofilm phenotype (Lauderdale
et al., 2009). Similar to the previous findings, the LAC ica
formed robust biofilms similar to LAC WT (data not shown),
again confirming that the new coverslip assay provides an effective
means to assess S. aureus biofilm formation.
CLSM OF COVERSLIP BIOFILMS
An important advantage to the coverslip method is the feasibil-
ity of confocal microscopy imaging of the biofilms. To prepare
samples for imaging, the biofilms were grown and harvested as
described above, and the coverslips were subjected to Live/Dead
staining using SYTO9 and TO-PRO3 dyes and a z series of images
was collected by confocal laser scanning microscopy (CLSM).
The image analysis of LAC WT grown on 20% human plasma
revealed thick, structured biofilms with profuse staining of live
cells and relatively few dead cells (Figure 2A). CLSM of LAC
WT grown on uncoated coverslips formed considerably thinner
biofilms with irregular structures (Figure 2B). While the LAC
strain can form robust biofilm structures in flow cells on abi-
otic surfaces (Lauderdale et al., 2009, 2010), the limited amount
of biomass accumulating on the uncoated coverslips observed
here mimics previous reports with microtiter plates (Beenken
et al., 2010), indicating optimal biofilm formation in this assay
is strongly dependent on surface conditioning. Previous reports
comparing S. aureus biofilm structure on uncoated vs. heparin-
coated coverslips also noted the strict dependence on surface
modification to induce biofilm formation (Shanks et al., 2005).
CLSM confirmed LAC sigB grown either on plastic or on 20%
human plasma-coated coverslips established poor biofilms with
little structural architecture (Figures 2A,B), supporting previous
flow cell observations with sigBmutants (Lauderdale et al., 2009).
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2012 | Volume 2 | Article 39 | 3
Walker and Horswill New assay for S. aureus biofilm formation
FIGURE 2 | CLSM Images of coverslip biofilms. LAC WT and LAC
sigB mutant biofilms were grown on human plasma-coated coverslips
(A) or untreated coverslips (B). The biofilm were post-stained with
SYTO9 (green) and TO-PRO3 (red), and a z series of images was
obtained with CLSM to visualize biofilm capacity. Each image shows a
larger top down (XY) view with cross-section views of biofilm depth on
the right (YZ) and bottom (XZ). Only top down (XY) images were taken
of LAC sigB grown on plastic due to the lack of cell adherence.
Biofilms did not form in the media only control wells (not shown).
Further analysis of the imaging revealed that only small clumps of
live cells were attached to the slide surface.
CONCLUSIONS
The ability of S. aureus to attach to surfaces and develop biofilm
communities complicates chronic infections, making them dif-
ficult to treat. Understanding the mechanisms employed to form
biofilms is essential for developing better treatment regimens, and
one valuable laboratory tool to define these mechanisms has been
the microtiter assay. High-throughput microtiter assays are a con-
venient and cost effective strategy to screen clinical isolates or
mutants for biofilm capacity, but the relevance of the observa-
tions and translation in vivo is sometimes questioned. Flow cells
could be a more biologically relevant mimic of the in vivo situ-
ation, but these assays have throughput and resource limitations
that can hamper experimental progress. The new coverslip assay
outlined in this study combines the benefits of microtiter and
flow cell assays and also integrates a biotic substratum for opti-
mal S. aureus attachment. We established that the new coverslip
assay is effective for monitoring biofilm formation by multiple,
wild-type MRSA isolates. Mutant strains with known biofilm
phenotypes also behaved as anticipated, demonstrating the new
coverslip assay is robust and provides results consistent with other
assays. The ability to form a biofilm showed a strong dependence
on plasma coating of the coverslip, which parallels observa-
tions made with microtiter plate assays. The addition of human
matrix proteins could facilitate studies on adherence proteins,
transcriptional regulators, and other virulence factors that have
potential roles in biofilmmaturation and dispersal. Transitioning
the coverslip biofilms to CLSM was also uncomplicated, provid-
ing another means to visualize biofilm phenotypes. Additionally,
various surfaces such as glass, polycarbonate, or metals such as
stainless steel or aluminum can potentially be substituted for the
polyvinyl plastic coverslips to adapt this method to other rele-
vant conditions, although many of these surfaces prevent efficient
microscopic analysis. Altogether, the new coverslip method is a
straightforward approach to quantifying and imaging S. aureus
biofilms on biotic surfaces that should facilitate future studies in
this important area of research.
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